Advanced glycation end products, oxidation products, and the extent of atherosclerosis during the VA diabetes trial and follow-up study

Aramesh Saremi, Scott Howell, Dawn C. Schwenke, Gideon Bahn, Paul J. Beisswenger, Peter D. Reaven

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Advanced glycation end products, oxidation products, and the extent of atherosclerosis during the VA diabetes trial and follow-up study'. Together they form a unique fingerprint.

Medicine & Life Sciences